Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure
NCT01847690 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2013-12-02
Summary
The conventional glucocorticoid replacement therapy in primary adrenal insufficiency- Addison's disease,renders the cortisol levels unphysiological, which may cause symptoms and long-term complications. Many patients take stress-doses that are extra doses of hydrocortisone or cortisone acetate before or during stressful physical or psychological events. However, the effect of such dosing has not been tested in scientific studies. In this double blind cross-over designed pilot trial we aim to test the effect of an extra dose of cortisol on physical activity and hormone levels.
Conditions
- Addison Disease
Interventions
- DRUG
-
Hydrocortisone
Cortef 5 mg tablets per os, 2x5 mg, one day, one time
Sponsors & Collaborators
-
Haukeland University Hospital
lead OTHER
Principal Investigators
-
Eystein Husebye, Professor · Haukeland University Hospital
-
Katerina Simunkova, MUDr. PhD · Haukeland University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2014-01-31
- Completion
- 2014-03-31
Countries
- Norway
Study Locations
More Related Trials
-
The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism
NCT02360046 ·Status: TERMINATED ·Phase: NA
-
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
NCT00688987 ·Status: COMPLETED ·Phase: NA
-
Cushing's Syndrome Before and After Treatment (CORRECT)
NCT05521529 ·Status: RECRUITING
-
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
NCT00529841 ·Status: COMPLETED ·Phase: NA
-
Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
NCT01246739 ·Status: TERMINATED ·Phase: NA
-
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582 ·Status: COMPLETED ·Phase: NA
-
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency
NCT01450930 ·Status: COMPLETED ·Phase: PHASE2
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Does Relative Hypoglycaemia &/or Sleep Disturbance Contribute to the Lethargy Observed in Addison's Disease
NCT05515055 ·Status: UNKNOWN
-
Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004343 ·Status: UNKNOWN
-
Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment
NCT00975078 ·Status: COMPLETED ·Phase: PHASE4
-
Self-management in Patients With Adrenal Insufficiency.
NCT06637722 ·Status: ACTIVE_NOT_RECRUITING
-
Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)
NCT04461535 ·Status: COMPLETED ·Phase: NA
-
Updated Diagnostic Cortisol Values for Adrenal Insufficiency
NCT05149638 ·Status: RECRUITING ·Phase: NA
-
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
NCT05193396 ·Status: RECRUITING ·Phase: PHASE4
-
Adrenal Function in GHD Children
NCT03203356 ·Status: COMPLETED
-
Hyperprolactinemia and Adrenal Steroidogenesis
NCT04146389 ·Status: TERMINATED
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 ·Status: RECRUITING
-
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism
NCT05826080 ·Status: UNKNOWN
-
Biomarker(s) for Glucocorticoids
NCT02152553 ·Status: COMPLETED ·Phase: NA
-
Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
NCT01771328 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992 ·Status: UNKNOWN ·Phase: NA
-
GH and Cardiovascular Risk Factors
NCT01877512 ·Status: COMPLETED ·Phase: PHASE4